{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:28:23Z","timestamp":1793647703484,"version":"4.5.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2018-I2M-2-002"],"award-info":[{"award-number":["2018-I2M-2-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.virol.2026.111049","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:23:01Z","timestamp":1786749781000},"page":"111049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro"],"prefix":"10.1016","volume":"624","author":[{"given":"Salik","family":"Nazki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Kailath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rein\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9980-4505","authenticated-orcid":false,"given":"Bruno","family":"Douradinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.111049_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.111049_bib2","doi-asserted-by":"crossref","first-page":"7499","DOI":"10.1073\/pnas.1017146108","article-title":"Adenovirus type-35 vectors block human CD4 + T-cell activation via CD46 ligation","volume":"108","author":"Adams","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2026.111049_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.30","article-title":"Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens","volume":"3","author":"Afkhami","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.virol.2026.111049_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009117","article-title":"Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infection","volume":"17","author":"Akidil","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.111049_bib5","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1096\/fasebj.4.11.2199285","article-title":"Integrins and other cell adhesion molecules","volume":"4","author":"Albelda","year":"1990","journal-title":"FASEB J."},{"key":"10.1016\/j.virol.2026.111049_bib6","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1016\/j.vaccine.2017.05.032","article-title":"ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice","volume":"35","author":"Alharbi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.111049_bib7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/mt.2013.284","article-title":"Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza A antigens","volume":"22","author":"Antrobus","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2026.111049_bib8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/1352458514560923","article-title":"Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis","volume":"21","author":"Aung","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.virol.2026.111049_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl8213","article-title":"ChAdOx1 interacts with CAR and PF4 with implications for thrombosis with thrombocytopenia syndrome","volume":"7","author":"Baker","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2026.111049_bib10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1172\/JCI23743","article-title":"Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates","volume":"115","author":"Bashuda","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virol.2026.111049_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010083","article-title":"The RGD-binding integrins \u03b1v\u03b26 and \u03b1v\u03b28 are receptors for mouse adenovirus-1 and -3 infection","volume":"17","author":"Bieri","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.111049_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772240","article-title":"Intranasal delivery of MVA Vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents","volume":"12","author":"Bo\u0161njak","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1080\/14760584.2023.2282065","article-title":"Have mRNA vaccines sentenced DNA vaccines to death?","volume":"22","author":"Cagigi","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2026.111049_bib14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1086\/509258","article-title":"Phase 1 safety and immunogenicity evaluation of a multiclade HIV\u20101 candidate vaccine delivered by a replication\u2010defective recombinant adenovirus vector","volume":"194","author":"Catanzaro","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111049_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.3390\/vaccines11020432","article-title":"Adenoviral vector-based vaccine platform for COVID-19: current status","volume":"11","author":"Chavda","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111049_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/0022-1317-83-1-151","article-title":"Chimpanzee adenovirus CV-68 adapted as a gene delivery vector interacts with the coxsackievirus and adenovirus receptor","volume":"83","author":"Cohen","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2020.00909","article-title":"Factors which contribute to the immunogenicity of non-replicating adenoviral vectored vaccines","volume":"11","author":"Coughlan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep16756","article-title":"Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice","volume":"5","author":"Dicks","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.111049_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040385","article-title":"A novel chimpanzee Adenovirus Vector with low human seroprevalence: improved systems for Vector derivation and comparative immunogenicity","volume":"7","author":"Dicks","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.111049_bib20","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1476-8518-9-6","article-title":"Immunization with genetically attenuated P52-deficient Plasmodium berghei sporozoites induces a long-lasting effector memory CD8+ T cell response in the liver","volume":"9","author":"Douradinha","year":"2011","journal-title":"J. Immune Base Ther. Vaccine"},{"key":"10.1016\/j.virol.2026.111049_bib21","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1038\/s41467-021-23752-2","article-title":"Targeted PI3K\/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia","volume":"12","author":"Ecker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.111049_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00869-19","article-title":"The coxsackievirus and adenovirus receptor, a required host factor for recovirus infection, is a putative enteric calicivirus receptor","volume":"93","author":"Farkas","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/vaccines7020040","article-title":"Safety and immunogenicity of a novel recombinant simian Adenovirus ChAdOx2 as a vectored vaccine","volume":"7","author":"Folegatti","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111049_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1473-3099(20)30160-2","article-title":"Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial","volume":"20","author":"Folegatti","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2026.111049_bib25","doi-asserted-by":"crossref","first-page":"5248","DOI":"10.1016\/j.vaccine.2022.06.008","article-title":"Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: standardized template with key considerations for a risk\/benefit assessment","volume":"40","author":"Folegatti","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.111049_bib26","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/nm952","article-title":"CD46 is a cellular receptor for group B adenoviruses","volume":"9","author":"Gaggar","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2026.111049_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41541-024-00895-z","article-title":"Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines","volume":"9","author":"Gardner","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2026.111049_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/vaccines14030260","article-title":"Development and evaluation of compact semi-synthetic promoters for enhanced antigen expression in adenoviral-vectored vaccines","volume":"14","author":"Hlav\u00e1\u010d","year":"2026","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.virol.2026.111049_bib29","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.virol.2026.111049_bib30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/intimm\/dxq474","article-title":"Ligation of CD46 to CD40 inhibits CD40 signaling in B cells","volume":"23","author":"Jabara","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib31","doi-asserted-by":"crossref","first-page":"e663","DOI":"10.1016\/S2666-5247(22)00126-4","article-title":"Safety and immunogenicity of a simian-adenovirus-vectored rabies vaccine: an open-label, non-randomised, dose-escalation, first-in-human, single-centre, phase 1 clinical trial","volume":"3","author":"Jenkin","year":"2022","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.virol.2026.111049_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1473-3099(23)00068-3","article-title":"Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial","volume":"23","author":"Jenkin","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2026.111049_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jim.2005.06.010","article-title":"Efficient gene transfer into normal human B lymphocytes with the chimeric adenoviral vector AD5\/F35","volume":"304","author":"Jung","year":"2005","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2026.111049_bib34","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1128\/JVI.05760-11","article-title":"Identification of Adenovirus Serotype 5 hexon regions that interact with scavenger receptors","volume":"86","author":"Khare","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib35","first-page":"376","article-title":"Efficient transduction with recombinant adenovirus in EBV-transformed B lymphoblastoid cell lines","volume":"37","author":"Kim","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.virol.2026.111049_bib36","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.4049\/jimmunol.1002170","article-title":"Beraprost enhances the APC function of B cells by upregulating CD86 expression levels","volume":"186","author":"Kim","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4049\/jimmunol.122.2.549","article-title":"Establishment and characterization of BALB\/c lymphoma lines with B cell properties","volume":"122","author":"Kim","year":"1979","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib38","doi-asserted-by":"crossref","first-page":"10862","DOI":"10.1128\/JVI.00928-12","article-title":"Adenovirus serotype 26 utilizes CD46 as a primary cellular receptor and only transiently activates T lymphocytes following vaccination of rhesus monkeys","volume":"86","author":"Li","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib39","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-026-05714-x","article-title":"Immunoinformatics-guided design of a conserved multi-epitope vaccine candidate against pathogenic human coronaviruses","author":"Lim","year":"2026","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.virol.2026.111049_bib40","series-title":"Adenoviral Vectors for Gene Therapy","first-page":"27","article-title":"Biology of Adenovirus cell entry","author":"Luisoni","year":"2016"},{"key":"10.1016\/j.virol.2026.111049_bib41","doi-asserted-by":"crossref","first-page":"14429","DOI":"10.1128\/JVI.79.22.14429-14436.2005","article-title":"CD46 is a cellular receptor for all species B adenoviruses except types 3 and 7","volume":"79","author":"Marttila","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib42","article-title":"Adenovirus transcriptome in human cells infected with ChAdOx1-Vectored candidate HIV-1 vaccine is dominated by high levels of correctly spliced HIVconsv1&62 transgene RNA","volume":"11","author":"Matthews","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111049_bib43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0002-9440(10)65223-6","article-title":"The role of B lymphocytes in coxsackievirus B3 infection","volume":"155","author":"Mena","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.virol.2026.111049_bib44","article-title":"Single-Dose intranasal immunization with ChAd68-Vectored prefusion F vaccines confers sustained protection against respiratory syncytial virus in murine models","volume":"13","author":"Miao","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.virol.2026.111049_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/fvl-2016-0070","article-title":"Simian adenoviruses as vaccine vectors","volume":"11","author":"Morris","year":"2016","journal-title":"Future Virol."},{"key":"10.1016\/j.virol.2026.111049_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2026.199691","article-title":"Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro","volume":"364","author":"Nazki","year":"2026","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2026.111049_bib47","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.20021395","article-title":"BCL6 controls the expression of the B7-1\/CD80 costimulatory receptor in germinal Center B cells","volume":"198","author":"Niu","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2026.111049_bib48","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/gt.2017.25","article-title":"Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo","volume":"24","author":"Palma","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2026.111049_bib49","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1007\/s00253-019-09842-8","article-title":"Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8(+) T cells ex vivo","volume":"103","author":"Palma","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virol.2026.111049_bib50","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.3892\/ijo.2013.2091","article-title":"CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas\/FasL pathway","volume":"43","author":"Park","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.virol.2026.111049_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020732118","article-title":"Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46","volume":"118","author":"Persson","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2026.111049_bib52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/309030a0","article-title":"Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule","volume":"309","author":"Pierschbacher","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.111049_bib53","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1473-3099(20)30476-X","article-title":"Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial","volume":"21","author":"Pollard","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2026.111049_bib54","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/infdis\/jiw244","article-title":"Safety and high level efficacy of the combination Malaria vaccine regimen of RTS,S\/AS01 B with Chimpanzee Adenovirus 63 and modified vaccinia Ankara vectored vaccines expressing ME-TRAP","volume":"214","author":"Rampling","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2026.111049_bib55","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.4049\/jimmunol.0803783","article-title":"B7-1\/2 (CD80\/CD86) direct signaling to B cells enhances IgG Secretion1","volume":"183","author":"Rau","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2026.111049_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.147688","article-title":"A retrospective computational validation of a clinically evaluated recombinant envelope protein tetravalent dengue vaccine","author":"Rein\u00e9","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.virol.2026.111049_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2026.108890","article-title":"In silico post-hoc analysis of a clinically tested recombinant West Nile virus envelope protein vaccine","author":"Rein\u00e9","year":"2026","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.virol.2026.111049_bib58","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.ymthe.2023.07.004","article-title":"Adenoviral vectors infect B lymphocytes in vivo","volume":"31","author":"Rice-Boucher","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2026.111049_bib59","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1099\/vir.0.80806-0","article-title":"Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie\u2013adenovirus receptor and \u03b1v\u03b25 integrin expression","volume":"86","author":"Richardson","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib60","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1099\/vir.0.80806-0","article-title":"Susceptibility of B lymphocytes to adenovirus type 5 infection is dependent upon both coxsackie\u2013adenovirus receptor and \u03b1v\u03b25 integrin expression","volume":"86","author":"Richardson","year":"2005","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib61","doi-asserted-by":"crossref","first-page":"7909","DOI":"10.1128\/JVI.72.10.7909-7915.1998","article-title":"The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F","volume":"72","author":"Roelvink","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib62","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib63","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2514356","article-title":"Developing the next-generation of adenoviral vector vaccines","volume":"21","author":"Sampson","year":"2025","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.111049_bib64","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/jgm.1588","article-title":"Intracellular trafficking and fate of chimeric adenovirus 5\/F35 in human B lymphocytes","volume":"13","author":"Samson","year":"2011","journal-title":"J. Gene Med."},{"key":"10.1016\/j.virol.2026.111049_bib65","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.1128\/JVI.77.17.9183-9191.2003","article-title":"Adenovirus type 11 uses CD46 as a cellular receptor","volume":"77","author":"Segerman","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib66","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virusres.2006.07.009","article-title":"Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors","volume":"122","author":"Short","year":"2006","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2026.111049_bib67","doi-asserted-by":"crossref","DOI":"10.3791\/3573","article-title":"Assessing somatic hypermutation in ramos B cells after overexpression or knockdown of specific genes","author":"Upton","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.virol.2026.111049_bib68","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","volume":"586","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.111049_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.74.1.354-362.2000","article-title":"Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells","volume":"74","author":"Von Seggern","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.111049_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.111049_bib71","article-title":"Immunological Study of reconstructed common ancestral sequence of Adenovirus Hexon protein","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.111049_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0092-8674(93)90231-E","article-title":"Integrins \u03b1v\u03b23 and \u03b1v\u03b25 promote adenovirus internalization but not virus attachment","volume":"73","author":"Wickham","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.virol.2026.111049_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112470","article-title":"Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination","volume":"42","author":"Yin","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.virol.2026.111049_bib74","first-page":"2311","article-title":"Adenovirus type 5 substituted with type 11 or 35 fiber structure increases its infectivity to human cells enabling dual gene transfer in CD46-dependent and -independent manners","volume":"27","author":"Yu","year":"2007","journal-title":"Anticancer Res."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:54:54Z","timestamp":1793645694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":74,"alternative-id":["S0042682226002643"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.111049","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential ChAdOx1 and ChAdOx2 transduction efficiency and receptor specificity in human and mouse B cell lines in vitro","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.111049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111049"}}